IXICO plc (AIM:IXI)
London · Delayed Price · Currency is GBP · Price in GBX 8.87
+0.22 (2.60%)
May 26, 2026, 3:44 PM GMT
IXICO Market Cap
IXICO has a market cap or net worth of 19.08 million as of May 26, 2026. Its market cap has increased by 122.58% in one year.
Market Cap
19.08M
Enterprise Value
17.96M
Revenue
7.28M
Ranking
n/a
PE Ratio
n/a
Stock Price
8.87
Market Cap Chart
Since October 15, 2013, IXICO's market cap has increased from 8.82M to 19.08M, an increase of 116.27%. That is a compound annual growth rate of 6.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 26, 2026 | 19.08M | 75.22% |
| Dec 31, 2025 | 10.89M | - |
| Dec 31, 2024 | 10.89M | 80.16% |
| Dec 29, 2023 | 6.04M | -50.98% |
| Dec 30, 2022 | 12.33M | -57.32% |
| Dec 31, 2021 | 28.89M | -40.15% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Poolbeg Pharma | 35.54M |
| Sareum Holdings | 28.41M |
| ImmuPharma | 26.83M |
| SkinBioTherapeutics | 25.14M |
| Arecor Therapeutics | 24.92M |
| Aptamer Group | 19.87M |
| Palatin Technologies | 19.12M |
| Fusion Antibodies | 15.94M |